1. Home
  2. CFFN vs GOSS Comparison

CFFN vs GOSS Comparison

Compare CFFN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$6.99

Market Cap

796.8M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.67

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
GOSS
Founded
1893
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
796.8M
726.8M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
CFFN
GOSS
Price
$6.99
$3.67
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$6.75
$8.60
AVG Volume (30 Days)
787.6K
3.0M
Earning Date
01-28-2026
11-05-2025
Dividend Yield
4.86%
N/A
EPS Growth
79.31
N/A
EPS
0.52
N/A
Revenue
$200,291,000.00
$44,051,000.00
Revenue This Year
$16.44
N/A
Revenue Next Year
$3.40
$6.41
P/E Ratio
$13.46
N/A
Revenue Growth
20.62
N/A
52 Week Low
$4.90
$0.76
52 Week High
$7.08
$3.80

Technical Indicators

Market Signals
Indicator
CFFN
GOSS
Relative Strength Index (RSI) 70.11 69.66
Support Level $6.67 $3.34
Resistance Level $7.08 $3.80
Average True Range (ATR) 0.12 0.20
MACD 0.04 0.02
Stochastic Oscillator 90.00 83.64

Price Performance

Historical Comparison
CFFN
GOSS

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: